What Has Been the Growth of the Digital Insomnia Therapeutics Market So Far?
The digital insomnia therapeutics market has seen considerable growth due to a variety of factors.
• In recent times, the digital insomnia therapeutics market has seen robust growth. The market which was valued at $3.27 billion in 2024 is projected to escalate to $3.49 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 6.64%.
The substantial growth during the historical period has been driven by factors such as an increased emphasis on sleep disorder awareness, enhancement in cross-platform compatibility, proliferation of eco-friendly devices, development of sustainable digital therapeutics options, and a heightened focus on mental health.
What Is the Forecasted Market Size and Growth Rate for The Digital Insomnia Therapeutics Market?
The digital insomnia therapeutics market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for the digital insomnia therapeutics market to witness robust growth in the coming years, with a forecasted value of $4.47 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.38%.
This anticipated growth can be traced back to several factors, such as the embrace of virtual reality in sleep therapy, the increased focus on user-friendly platforms, a rise in funding towards sleep research, growth of voice-assisted sleep therapeutic solutions, and acceptance of hybrid sleep treatment models. Key future trends include advancements in the digital health technology, the incorporation of cognitive behavioural therapy, the use of AI and machine learning for enhanced treatment approaches, integration with various health applications, and the launching of multilingual platforms.
Which Drivers Are Accelerating Growth In The Digital Insomnia Therapeutics Market?
Digital health, consisting of digital technologies, tools, and platforms used to improve healthcare delivery, patient outcomes and facilitate personal health management, is being increasingly adopted. This trend is projected to boost the digital insomnia therapeutics market. This rise in digital health adoption is owing to factors such as the escalating need for affordable and accessible healthcare solutions, the increasing incidence of chronic diseases, greater awareness of preventive care, and the spread of telehealth services. Digital insomnia therapeutics play a part in digital health by offering tech-based solutions like mobile applications and wearable devices that track, diagnose, and manage sleep disorders while fostering better overall health results and integration with larger healthcare systems. Rock Health, a US corporation, reported in February 2024 that their 2022 survey showed an 8% increase to 80% from 72% in respondents who have ever used telemedicine. As such, the growth of digital insomnia therapeutics market is being buoyed by the enhancing adoption of digital health.
What Key Areas Define The Segmentation Of The Global Digital Insomnia Therapeutics Market?
The digital insomnia therapeutics market covered in this report is segmented –
1) By Type: Sleep Tracking Apps, Relaxation And Meditation Apps, Cognitive-Behavioral Therapy For Insomnia (CBT-I), Wearable Devices, Other Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
3) By Applications: Medical, Household
Subsegments:
1) By Sleep Tracking Apps: Basic Sleep Monitoring Apps, Advanced Sleep Monitoring Apps, Smart Alarm Apps
2) By Relaxation And Meditation Apps: Guided Meditation Apps, Breathing Exercise Apps, Sleep-Inducing Music Apps
3) By Cognitive-Behavioral Therapy For Insomnia (CBT-I): Digital CBT-I Programs, CBT-I Mobile Apps, Online CBT-I Therapy Platforms
4) By Wearable Devices: Sleep-Tracking Wearables, Smartwatches With Sleep Tracking, Wearable Devices With Biofeedback For Insomnia
5) By Other Types: Virtual Reality (VR) Therapy For Insomnia, Biofeedback Devices, Transcranial Magnetic Stimulation (TMS) Devices For Sleep
Pre-Book The Digital Insomnia Therapeutics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Digital Insomnia Therapeutics Market?
Leaders in the digital insomnia therapeutics market, such as Big Health Inc., are shifting their focus towards the creation of advanced solutions like software-based mobile applications. These apps, intended for smartphones and tablets, offer personalised, easily accessible, and cost-effective ways to tackle insomnia. Features like sleep tracking, relaxation techniques, cognitive behavioural therapy, and custom sleep advice are included in these digital tools to manage insomnia. For instance, Big Health Inc., a company nestled in the United States that specialises in mental health services, obtained the approval of the United States Food and Drug Administration in August 2024 for SleepioRx. SleepioRx is designed as a supplementary treatment to standard care for adult chronic insomnia. The application adopts proven techniques to address the cognitive and behavioural contributors to chronic insomnia and sleep disorders, intended for adults aged 18 and above.
Who Are the Key Players in the Digital Insomnia Therapeutics Market?
Major companies operating in the digital insomnia therapeutics market are include:
• Pear Therapeutics Inc.
• Zuellig Pharma Holdings Limited
• Calm.com Inc.
• Headspace Inc.
• Big Health Inc.
• Click Therapeutics Inc.
• Silvercloud Health Limited
• Nox Health Group Inc.
• OPTT Inc.
• Curve Health Inc.
• Bodymatter Inc.
• Sana Health Group
• SleepCogni Limited
• Stellar Sleep
• Somnus Therapeutics Inc.
• SleepScore Labs
• HoneyNaps USA Inc.
• Sliiip
• Neurovalens Ltd.
• WELT Corp
What Is The Most Dominant Region In The Digital Insomnia Therapeutics Market?
North America was the largest region in the digital insomnia therapeutics market in 2024. The regions covered in the digital insomnia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
